Search Results 951-960 of 11269 for Antifungal Resistance

  1. A Study To Evaluate Safety And Effectiveness Of SHP647 As Induction Therapy In Participants With Moderate-to- Severe Crohn's Disease - Mayo Clinic

    ... fungal infections such as histoplasmosis or ... resistance are <5%. Subjects from regions with ... Subjects from regions with higher rates of primary multidrug TB ...

  2. Rovalpituzumab Tesirine In Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

    Any active Grade 3 or higher (according to NCI CTCAE version 4.03) viral, bacterial, or fungal infection within 2 weeks of the first dose of the study drug.

  3. Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  4. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    ... resistant TB infections are < 5% or an acceptable alternative regimen) or active TB (acceptable multi-drug regimen). In these cases, no QuantiFERON® TB-Gold ...

  5. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... fungal, mycobacterial, parasitic, or other infection (excluding fungal infections of nail beds) at study enrollment * Evidence of any significant ...

  6. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic study finds 1 in 8 adults carries hidden genetic risk — and reveals what · Mayo Clinic researchers identify molecule linked to treatment-resistant ...

  7. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease featured image. Research. Mayo Clinic researchers identify ...

  8. A Dose Escalation Study Of Amivantamab In Participants With Advanced Non-Small Cell Lung Cancer - Mayo Clinic

    Cohort C: Subjects with primary EGFR mutated disease, with a documented EGFR alteration (e.g., C797S) mediating resistance to previous treatment with a ...

  9. General Internal Medicine - Clinical trials

    This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical ...

  10. Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck Cancer - Mayo Clinic

    * No requirement for concurrent antibiotics or antifungal agents for the prevention of opportunistic infections; * ... * Acute bacterial or fungal ...